Skip to main content
v2026.11,986 entries · CC-BY 4.0

Editorial · CASRAI · Clinical research and clinical trials

CMS Files Contract Year 2028 Medicare Advantage and Part D Policy Proposed Rule

CMS has proposed major CY 2028 Medicare Advantage reforms, standardizing healthy food benefits and testing the mandatory ADVaNCE MA payment model.

Published 22 Nov 2026· 7 minute read
Main entrance to the Hubert H. Humphrey Building, headquarters of the U.S. Department of Health and Human Services in Washington, D.C.
Photo: G. Edward Johnson / Wikimedia Commons, CC BY 4.0 (cropped). Source · Licence

On November 20, 2026, the Centers for Medicare and Medicaid Services filed a major proposed rule for Contract Year 2028 that establishes strict nutritional standards for supplemental benefits and introduces the first mandatory Medicare Advantage model from the CMS Innovation Center. The 868-page regulatory package reshapes compliance, clinical demonstration trials, and billing workflows across university health systems and academic medical centers.

What Happened: CMS Files Major Contract Year 2028 Policy Package

On November 20, 2026, the Centers for Medicare and Medicaid Services (CMS) officially filed a comprehensive proposed rule titled “Medicare Program; Contract Year 2028 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Programs of All-Inclusive Care for the Elderly.” The filing, designated under Federal Register Document 2026-23960 (File Code CMS-4214-P2, RIN 0938-AV88, Docket CMS-2026-3533), spans 868 pages and represents the second major regulatory action for Contract Year (CY) 2028. It follows an initial statutory rule published in October 2026 implementing provisions of the Consolidated Appropriations Act, 2026.

The proposed rule introduces structural guardrails to address plan marketing, beneficiary access, and supplemental benefit utilization. As detailed in the agency’s accompanying CMS fact sheet, the federal government aims to eliminate non-nutritive grocery allowances, curb aggressive enrollment tactics, and test localized competition among private plans. Publication opens a 60-day public comment window from its scheduled November 25, 2026 Federal Register date through late January 2027.

Key Regulatory Details and Operational Parameters

The proposed rule codifies a formal definition of “healthy food” under Medicare Advantage (MA) supplemental benefits. Plans have broadly offered grocery cards under Special Supplemental Benefits for the Chronically Ill (SSBCI) and primarily health-related categories. CMS found that millions in allowances were spent on ultra-processed goods, sodas, and convenience snacks rather than disease-mitigating nutrition. Under the new standard, covered food items must align with the 2025–2030 Dietary Guidelines for Americans, restricted to nutrient-dense foods like fresh produce and whole grains. Exceptions require a direct clinical recommendation from a treating healthcare provider to address documented medical needs.

The CMS Innovation Center (CMMI) also introduced the Aligning Data and Value to Nurture Competition and Efficiency in Medicare Advantage (ADVaNCE MA) model. ADVaNCE MA is CMMI’s first mandatory demonstration in Medicare Advantage. Pre-implementation begins June 8, 2027, with mandatory participation for plans in randomly selected states starting January 1, 2029. Rather than relying solely on national Star Ratings, the model introduces localized “Diamond Ratings” that benchmark plan performance and Quality Bonus Payments against regional competitors serving similar clinical cohorts.

Regulatory Domain Current Regulatory Practice (CY 2026–2027) Proposed CY 2028 Rule (CMS-4214-P2) Target Program Mechanism
Healthy Food Supplemental Benefits Flexible plan-defined grocery cards; coverage of non-nutritive convenience items Strict alignment with 2025–2030 Dietary Guidelines for Americans; provider prescription required for non-standard items SSBCI and primarily health-related supplemental benefits (42 CFR § 422.102)
CMMI Medicare Advantage Testing Voluntary demonstration models (e.g., Value-Based Insurance Design / VBID) Mandatory 10-year ADVaNCE MA model in randomly selected states with localized Diamond Ratings Social Security Act § 1115A demonstration authority
Star Ratings Methodology Broad 40+ measure set; reward factor for low variance; expansive hold-harmless thresholds Streamlined 15-measure set prioritizing outcomes; reward factor removed; hold-harmless limited to contracts with 4.5+ stars Quality Bonus Payment calculation (42 CFR § 422.166)
Special Enrollment Periods (SEPs) Broad exceptional-condition and emergency SEPs utilized for ongoing marketing enrollment Prior CMS affirmative approval required before invoking disaster and emergency enrollment flexibilities MA and Part D enrollment regulations (42 CFR § 422.62)

Network adequacy rules are also adjusted to lower market barriers. Newly contracting plans may demonstrate compliance with provider network standards during their initial operating year rather than during application submission. In addition, cost-sharing for ground ambulance and emergency services faces stricter limits, and enrollees receive a 90-day continuity-of-care buffer if an in-network provider terminates its contract.

Background and Regulatory Context

Supplemental benefit expansion stems from the CHRONIC Care Act of 2018, which authorized MA organizations to offer non-primarily health-related benefits to chronically ill enrollees. Enrollment in plans offering SSBCI grew rapidly, turning grocery allowances into a dominant advertising feature in broker campaigns.

However, federal oversight bodies raised repeated warnings regarding programmatic integrity. Reports from MedPAC and the HHS Office of Inspector General (OIG) documented that plans rarely tracked health outcomes associated with non-clinical card allowances, while OIG flagged aggressive marketing organizations enrolling beneficiaries on promises of free groceries.

CMS-4214-P2 complements CMS-4214-P, the October 2026 proposed rule that established letter-grade provider directory accuracy requirements under the Consolidated Appropriations Act, 2026. The new package also reinforces earlier utilization management standards, including Medicare Advantage prior authorization guardrails under 42 CFR § 422.101 designed to curb algorithmic denials and protect clinical necessity reviews.

Stakeholder Reactions and Market Response

The proposed rule generated immediate reaction across healthcare administration and health policy circles. Sector reporting from HealthExec noted that CMS is focusing on clinical accountability after rapid supplemental benefit growth complicated plan comparison for seniors.

Regulatory analysis from American Health Intel highlighted the disruptive nature of the mandatory ADVaNCE MA demonstration. Analysts observed that establishing localized “Diamond Ratings” departs from CMMI’s tradition of voluntary participation. Regional health plans welcomed local benchmarking as a way to compete against national carriers that cross-subsidize multi-state contracts.

Commercial payer representatives raised concerns regarding the operational burden of verifying food item eligibility at point-of-sale systems. Conversely, clinical leadership organizations supported requiring provider recommendations for non-standard nutrition, emphasizing that medical dietary support belongs within coordinated clinical care plans.

What It Means for Researchers, Universities, and Academic Medical Centers

For academic medical centers (AMCs), university health systems, and health services researchers, CMS-4214-P2 affects clinical trials, billing compliance, and healthcare economics:

  • Food-as-Medicine Pragmatic Trials: Establishing a federal baseline for healthy food aligned with dietary guidelines provides a uniform control variable for multi-site clinical trials evaluating nutritional interventions in chronic illness cohorts.
  • Clinical Trial Routine Costs: AMCs must align Medicare Advantage rules with clinical research billing. Hospital billing offices rely on the Medicare Clinical Trial Policy (NCD 310.1) to separate research-induced costs from standard patient care, ensuring supplemental benefit changes do not distort trial billing ledgers.
  • Evaluating Demonstration Pathways: Health economists evaluating payer payment reforms can compare outcomes from the ADVaNCE MA model. The transition parallels analyses of Medicare coverage pathways including Coverage with Evidence Development (CED), offering natural experiment cohorts across states.
  • Hospital Revenue Cycle and Denial Defense: The 90-day provider continuity rule and emergency cost-sharing caps require AMC revenue teams to update patient access protocols. Clinical documentation teams can apply proven methodologies for clinical validation and billing denial defense to protect inpatient reimbursement against payer audits.
  • AMC Network Contracting: Academic health systems negotiating risk-bearing contracts with Medicare Advantage plans will need to evaluate localized quality bonus metrics under the proposed ADVaNCE MA framework, adjusting clinical quality measures to match regional payer performance pools.

What Happens Next: Implementation Timeline and Comment Window

CMS-4214-P2 outlines a clear multi-year implementation schedule across federal rulemaking and state demonstration cycles:

  • November 20, 2026: Proposed rule filed for public inspection with the Office of the Federal Register.
  • November 25, 2026: Official publication in the Federal Register under Document 2026-23960.
  • January 25, 2027: Formal 60-day public comment window closes at 5:00 p.m. Eastern Time under Docket CMS-2026-3533.
  • April 2027: CMS expects to release the final CY 2028 Medicare Advantage rule and annual rate announcement.
  • June 8, 2027: Pre-implementation operational phase begins for the CMMI ADVaNCE MA model in selected demonstration states.
  • January 1, 2028: Healthy food standards, tightened SEP approvals, and Part B maximum fair price rules take effect.
  • January 1, 2029: Mandatory ADVaNCE MA model participation begins for plans in designated demonstration states.
  • Contract Year 2030: The streamlined 15-measure Star Ratings system and revised hold-harmless rules take full operational effect.

Sources

Ask CASRAI · full access

Ask about this story

Full access: large monthly usage, up to 10 source passages behind each answer, and MCP and API access for Claude Code, Codex and other CLIs. Cancel any time.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →